tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market
BRNS
Barinthus Biotherapeutics
RESEARCH TOOLSreports

Barinthus Biotherapeutics (BRNS) Financial Statements

Compare
108 Followers

Barinthus Biotherapeutics Financial Overview

Barinthus Biotherapeutics's market cap is currently $22.47M. The company's EPS TTM is $-0.27; its P/E ratio is -0.43; Barinthus Biotherapeutics is scheduled to report earnings on March 13, 2026, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 14.97M$ 802.00K$ 44.70M$ 268.00K
Gross Profit$ -5.86M$ 14.97M$ 802.00K$ 44.70M$ 268.00K
Operating Income$ -54.19M$ -67.97M$ -83.91M$ -4.04M$ -45.22M
EBITDA$ -48.34M$ -55.37M$ -71.06M$ 5.19M$ -47.87M
Net Income$ -66.43M$ -61.07M$ -73.35M$ 5.34M$ -50.87M
Balance Sheet
Cash & Short-Term Investments$ 70.46M$ 110.66M$ 142.09M$ 194.38M$ 214.05M
Total Assets$ 98.17M$ 160.33M$ 214.51M$ 270.20M$ 280.71M
Total Debt$ 11.28M$ 12.01M$ 12.98M$ 8.77M$ 7.22M
Net Debt$ -59.17M$ -98.66M$ -129.11M$ -185.61M$ -206.83M
Total Liabilities$ 23.88M$ 30.19M$ 27.51M$ 27.00M$ 28.15M
Stockholders' Equity$ 74.21M$ 130.03M$ 186.78M$ 242.90M$ 252.13M
Cash Flow
Free Cash Flow$ -48.02M$ -29.83M$ -56.34M$ -20.57M$ -33.73M
Operating Cash Flow$ -47.98M$ -28.94M$ -50.92M$ -14.43M$ -32.58M
Investing Cash Flow$ 416.00K$ -892.00K$ -5.41M$ -5.75M$ -12.91M
Financing Cash Flow$ 2.00K$ 2.16M$ 1.87M$ 325.00K$ 222.74M
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History

Income Statement >

Barinthus Biotherapeutics Debt to Assets

Balance Sheet >

Barinthus Biotherapeutics Cash Flow

Cash Flow >

Barinthus Biotherapeutics Forecast EPS vs Actual EPS

Earnings >